The Latest Innovation in AcneTech™

The Latest Innovation in AcneTech™

The Accure Acne Laser System is FDA-cleared for the treatment of mild to severe inflammatory acne vulgaris on the face and body. Designed by and for dermatologists, the Accure treatment goes beyond the ordinary, delivering a transformative approach toward clear skin.

Using a 1726 nm wavelength laser with proprietary “treat-to-temperature” algorithm and forced-air cooling, the Accure Acne Laser System directs light energy at optimal depth in the skin to safely and effectively target overactive sebaceous glands (a root cause of acne) while preserving the surrounding healthy skin.

This new innovation can provide a fast response1 and dramatic results2 in all skin types3 without the side effects of prescription acne medications.

The Accure Acne Laser Advantage4

The Treatment Journey

Four simple treatments, recommended one month apart. 6 Treatments are performed in dermatologists’ offices exclusively.

Most patients experience little to no downtime. Expect no disruption to your regular schedule or activities.

Accure patients see a noticeable reduction in acne after just one treatment1, and an average 70% reduction in acne after 4 treatments.2

The most exciting aspect of Accure is going after one of the main causes of acne, which is sebum production. If you cut off sebum production, you cut off the fuel for the acne fire.

— E. Victor Ross, MD, Director of the Scripps Clinic Laser and Cosmetic Dermatology Center

Ready to Learn More?

Is your dermatology practice interested in learning how the Accure Acne Laser System can help your patients? Fill out this form and a member of our team will contact you.

Already offering the Accure Laser System in your practice?
Visit the Provider Portal to order supplies and access additional materials for your practice.

References:
  1. In multiple IRB-approved studies, patients showed an average 29% reduction after the first treatment. Data on file, Accure Acne, Inc. Individual results may vary.
  2. In IRB-approved studies, patients showed an average 70% reduction in acne lesions 6 months after 4 treatments, spaced 1 month apart. Data on file, Accure Acne, Inc. Individual results may vary.
  3. In multiple IRB-approved trials, patients of all Fitzpatrick skin types were included and treated, with no differences in target temperature or outcomes. Data on file, Accure Acne, Inc. Individual results may vary.
  4. Data on file, Accure Acne, Inc. Individual results may vary.
  5. IRB-approved clinical studies showed 79% boost-mode and 90% standard-mode responder rates with patients seeing a 50% or greater reduction in acne lesions up to 6 months after 4 treatments spaced one month apart. Data on file, Accure Acne, Inc. Individual results may vary.
  6. Dermatologist will determine a treatment plan based on each patient’s need. Individual results may vary.